Molbio Diagnostics Stock Price Analysis and Quick Research Report. Is Molbio Diagnostics an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Molbio Diagnostics. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Molbio Diagnostics has a PE ratio of 88.2695096492486 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Molbio Diagnostics has ROA of 9.7769% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Molbio Diagnostics has a Current ratio of 2.6303.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Molbio Diagnostics has a ROE of 13.6135%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Molbio Diagnostics has a Debt to Equity ratio of 0.2949 which means that the company has low proportion of debt in its capital.

• Sales growth: Molbio Diagnostics has reported revenue growth of 35.2301% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Molbio Diagnostics for the current financial year is 19.17606087416%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Molbio Diagnostics is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Molbio Diagnostics is Rs 12.5502. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Molbio Diagnostics in Ticker for free. Also, one can get the intrinsic value of Molbio Diagnostics by using Valuation Calculators, which are available with a Finology ONE subscription. 

Molbio Diagnostics FAQs

Q1. What is Molbio Diagnostics share price today?
Ans: The current share price of Molbio Diagnostics is Rs 1107.8.

Q2. What is the market capitalisation of Molbio Diagnostics?
Ans: Molbio Diagnostics has a market capitalisation of Rs 12766.28675688 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Molbio Diagnostics?
Ans: The PE ratio of Molbio Diagnostics is 88.2695096492486 and the P/B ratio of Molbio Diagnostics is 9.56372724643562, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Molbio Diagnostics share?
Ans: The 52-week high share price of Molbio Diagnostics is Rs 1264.6, and the 52-week low share price of Molbio Diagnostics is Rs 926.35.

Q5. Does Molbio Diagnostics pay dividends?
Ans: Currently, Molbio Diagnostics does not pay dividends. Dividend yield of Molbio Diagnostics is around 0%.

Q6. What are the face value and book value of Molbio Diagnostics shares?
Ans: The face value of Molbio Diagnostics shares is Rs 1, while the book value per share of Molbio Diagnostics is around Rs 115.8335. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Molbio Diagnostics?
Ans: Molbio Diagnostics has a total debt of Rs 334.586 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Molbio Diagnostics?
Ans: The ROE of Molbio Diagnostics is 13.6135% and ROCE of Molbio Diagnostics is 17.822%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Molbio Diagnostics a good buy for the long term?
Ans: The Molbio Diagnostics long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Molbio Diagnostics undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Molbio Diagnostics appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Molbio Diagnostics’s financials?
Ans: You can review Molbio Diagnostics’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.